Dr. María-Victoria Mateos, MD, PhD, is Consultant Physician in the Haematology Department and Associate Professor of Medicine at the University of Salamanca, Spain. She is the director of the Myeloma Program and coordinates the Clinical Trials Unit in Salamanca’s University Hospital Haematology Department.
She serves as coordinator of GEM (Spanish Myeloma Group), with direct involvement in the design and development of clinical trials. She has coordinated many clinical trials in elderly and smouldering MM patients that have profoundly influenced current options for treating these patient populations.
She has published over 200 papers in peer-reviewed international journals, some of which have become key references in the Multiple Myeloma field.
She is a member of the IMWG (International MM Working Group), IMS (International MM Society), EHA and ASH. Among her invited presentations, she has recently contributed to the educational sessions of EHA 2012, ASH 2013, ASCO 2015, EHA 2016, ASCO and ASH 2017.
She has served on the EHA’s Scientific Program Committee and Advisory Board since 2013 until 2018 and chair of the Scientific Program Committee for the 24th EHA congress in 2019. She has also served on the ASH Scientific Committee on plasma cell diseases in 2015-2019.
She has been a Councillor on the EHA Board between 2015-2018 and has been elected as member of the executive board on the EHA in 2019 for four additional years. She is member of the Steering Committee for the Society of Hematologic Oncology (SOHO) and member of the European School of Haematology (ESH) and European Myeloma Network (EMN) Scientific committee.
She has been member of the IMS board between 2016-2019 and involved in the education activities organised by the IMS in Latinoamérica as well as in the elaboration of slides with the major myeloma-related presentations after each ASH meeting to be used by the IMS members.